Nascent Pharma Holdings

NASC

OTCHealth Care

Income Statement

Total Revenue$950.76K

Gross Profit$864.2K

Operating Income$-2.74M

EBITDA$-2.99M

EBIT$-3.48M

Pre-tax Income$0

Net Income$-4.24M

Net Cash$0

Cash Equivalent$228.9K

Total Debt$1.04M

Net Debt$1.04M

Book Value$1.63M

Book Value Per Share0.66

Return on Equity (ROE)-553.17%

Return on Assets (ROA)-96.16%

Return on Invested Capital (ROI)-140.14%

Net Profit Margin-451.70%

Current Ratio0.48

Quick Ratio0.34

Long-Term Debt / Equity0.00